Monthly
US$200
Billed every month
Mecobalamin Tablets(甲钴胺片)
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 1 applicationAccepted: 2 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders35View records ↓
Under-review filings16View records ↓
This year’s generic filers8View records ↓
NHSA approval numbers41View records ↓
API companies with A status21View records ↓
Chemical-drug catalogue
Loaded records: 35 holders; 12 in the quality-and-efficacy consistency-evaluation category, and 21 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 重庆康刻尔制药股份有限公司 | 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 2025/12/30 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河南比福制药股份有限公司 | 河南比福制药股份有限公司 | 国药准字H20255795 | 2025/10/28 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 焦作市博信制药有限公司 | 焦作市明仁天然药物有限责任公司 | 国药准字H20255252 | 2025/08/26 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东鲁宁药业有限公司 | 山东鲁宁药业有限公司 | 国药准字H20255119 | 2025/08/19 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川成都同道堂制药有限责任公司 | 四川成都同道堂制药有限责任公司 | 国药准字H20254466 | 2025/06/03 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东齐都药业有限公司 | 山东齐都药业有限公司 | 国药准字H20254372 | 2025/05/27 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广东九明制药有限公司 | 广东九明制药有限公司 | 国药准字H20254370 | 2025/05/27 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海金不换兰考制药有限公司 | 上海金不换兰考制药有限公司 | 国药准字H20253999 | 2025/04/22 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南千金湘江药业股份有限公司 | 湖南千金湘江药业股份有限公司 | 国药准字H20253741 | 2025/03/25 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 苏州第壹制药有限公司 | 苏州爱美津制药有限公司 | 国药准字H20253592 | 2025/03/11 | 0.5mg | Not stated by source | CDE |
| 济南高华制药有限公司 | 济南高华制药有限公司 | 国药准字H20249835 | 2024/12/25 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 北京斯利安药业有限公司 | 北京斯利安药业有限公司 | 国药准字H20244778 | 2024/09/03 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川新斯顿制药股份有限公司 | 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 2024/07/22 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海新亚药业闵行有限公司 | 上海新亚药业闵行有限公司 | 国药准字H20052207 | 2024/07/12 | 0.5mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 宁夏洲洋制药有限公司 | 宁夏洲洋制药有限公司 | 国药准字H20244226 | 2024/06/28 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 烟台鲁银药业有限公司 | 烟台鲁银药业有限公司 | 国药准字H20244221 | 2024/06/28 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽九洲方圆制药有限公司 | 安徽九洲方圆制药有限公司 | 国药准字H20244262 | 2024/06/28 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏德源药业股份有限公司 | 江苏德源药业股份有限公司 | 国药准字H20244095 | 2024/06/18 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 北京春风药业有限公司 | 北京春风药业有限公司 | 国药准字H20243780 | 2024/05/21 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江京新药业股份有限公司 | 浙江京新药业股份有限公司 | 国药准字H20243796 | 2024/05/21 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏迪赛诺制药有限公司 | 江苏迪赛诺制药有限公司 | 国药准字H20052564 | 2024/02/26 | 0.5mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 成都通德药业有限公司 | 成都通德药业有限公司 | 国药准字H20243019 | 2024/01/09 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 北京民康百草医药科技有限公司 | 北京海王中新药业股份有限公司 | 国药准字H20234578 | 2023/12/05 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 惠升生物制药股份有限公司 | 吉林四环澳康药业有限公司 | 国药准字H20233571 | 2023/05/19 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 辰欣药业股份有限公司 | 辰欣药业股份有限公司 | 国药准字H20051425 | 2022/11/02 | 0.5mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 北京星昊医药股份有限公司 | 北京星昊医药股份有限公司 | 国药准字H20060865 | 2022/08/31 | 0.5mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 南京海鲸药业有限公司 | 南京海鲸药业有限公司 | 国药准字H20041642 | 2022/01/04 | 0.5mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 华北制药股份有限公司 | 华北制药股份有限公司 | 国药准字H20031126 | 2021/12/13 | 0.5mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 亚宝药业集团股份有限公司 | 亚宝药业集团股份有限公司 | 国药准字H20041767 | 2021/12/13 | 0.5mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 卓和药业集团有限公司 | 江苏四环生物制药有限公司 | 国药准字H20051410 | 2021/11/22 | 0.5mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 石药集团欧意药业有限公司 | 石药集团欧意药业有限公司 | 国药准字H20050168 | 2021/07/20 | 0.5mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 杭州康恩贝制药有限公司 | 杭州康恩贝制药有限公司 | 国药准字H20060921 | 2021/07/20 | 0.5mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 江西青峰药业有限公司 | 国药准字H20051440 | 2020/01/14 | 0.5mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 扬子江药业集团南京海陵药业有限公司 | 国药准字H20052325 | 2019/09/03 | 0.5mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 卫材（中国）药业有限公司 | 国药准字 H20143107 | 2014/04/30 | 0.5mg（薄膜衣片） | Other drug (其他药品) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 41 distinct approval numbers and 41 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 北京斯利安药业有限公司 | 国药准字H20244778 | 0.5mg | Category B (乙) | XB03BAJ038A001010100011 | NHSA |
| 北京星昊医药股份有限公司 | 国药准字H20060865 | 0.5mg | Category B (乙) | XB03BAJ038A001010100198 | NHSA |
| 赛灵药业科技集团股份有限公司 | 国药准字H20254370 | 0.5mg | Category B (乙) | XB03BAJ038A001010100299 | NHSA |
| 深圳市中联制药有限公司 | 国药准字H20050320 | 0.5mg | Category B (乙) | XB03BAJ038A001010100543 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001010101014 | NHSA |
| 辽宁亿帆药业有限公司 | 国药准字H20041229 | 0.5mg | Category B (乙) | XB03BAJ038A001010101272 | NHSA |
| 卓和药业集团股份有限公司 | 国药准字H20051410 | 0.5mg | Category B (乙) | XB03BAJ038A001010101490 | NHSA |
| 江苏迪赛诺制药有限公司 | 国药准字H20052564 | 0.5mg | Category B (乙) | XB03BAJ038A001010101495 | NHSA |
| 南京海鲸药业股份有限公司 | 国药准字H20041642 | 0.5mg | Category B (乙) | XB03BAJ038A001010101579 | NHSA |
| 苏州第壹制药有限公司 | 国药准字H20253592 | 0.5mg | Category B (乙) | XB03BAJ038A001010101649 | NHSA |
| 苏州爱美津制药有限公司 | 国药准字H20051774 | 0.5mg | Category B (乙) | XB03BAJ038A001010101667 | NHSA |
| 卫材(中国)药业有限公司 | 国药准字H20143107 | 0.5mg(薄膜衣片) | Category B (乙) | XB03BAJ038A001010101693 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20052325 | 0.5mg | Category B (乙) | XB03BAJ038A001010101748 | NHSA |
| 湖北广济药业股份有限公司 | 国药准字H20263341 | 0.5mg | Category B (乙) | XB03BAJ038A001010101803 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001010102068 | NHSA |
| 四川成都同道堂制药有限责任公司 | 国药准字H20254466 | 0.5mg | Category B (乙) | XB03BAJ038A001010102128 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001010102273 | NHSA |
| 华北制药股份有限公司 | 国药准字H20031126 | 0.5mg | Category B (乙) | XB03BAJ038A001010102702 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001010102770 | NHSA |
| 亚宝药业集团股份有限公司 | 国药准字H20041767 | 0.5mg | Category B (乙) | XB03BAJ038A001010102959 | NHSA |
| 上海金不换兰考制药有限公司 | 国药准字H20253999 | 0.5mg | Category B (乙) | XB03BAJ038A001010103059 | NHSA |
| 山东鲁宁药业有限公司 | 国药准字H20255119 | 0.5mg | Category B (乙) | XB03BAJ038A001010104104 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001010104127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20254372 | 0.5mg | Category B (乙) | XB03BAJ038A001010104145 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001010104240 | NHSA |
| 杭州康恩贝制药有限公司 | 国药准字H20060921 | 0.5mg | Category B (乙) | XB03BAJ038A001010104489 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20243796 | 0.5mg | Category B (乙) | XB03BAJ038A001010104658 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20253741 | 0.5mg | Category B (乙) | XB03BAJ038A001010104960 | NHSA |
| 江西科睿药业有限公司 | 国药准字H20051440 | 0.5mg | Category B (乙) | XB03BAJ038A001010105337 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001010105816 | NHSA |
| 宁夏洲洋制药有限公司 | 国药准字H20244226 | 0.5mg | Category B (乙) | XB03BAJ038A001010105908 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20244095 | 0.5mg | Category B (乙) | XB03BAJ038A001010106632 | NHSA |
| 焦作市博信制药有限公司 | 国药准字H20255252 | 0.5mg | Category B (乙) | XB03BAJ038A001010107193 | NHSA |
| 北京春风药业有限公司 | 国药准字H20243780 | 0.5mg | Category B (乙) | XB03BAJ038A001010109905 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20233571 | 0.5mg | Category B (乙) | XB03BAJ038A001010180760 | NHSA |
| 哈尔滨珍宝制药有限公司 | 国药准字H20244262 | 0.5mg | Category B (乙) | XB03BAJ038A001010181400 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001010183004 | NHSA |
| 湖南状元制药有限公司 | 国药准字H20256402 | 0.5mg | Category B (乙) | XB03BAJ038A001010183058 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20234578 | 0.5mg | Category B (乙) | XB03BAJ038A001010183644 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001010185352 | NHSA |
| 北京星昊医药股份有限公司 | 国药准字H20060865 | 0.5mg | Category B (乙) | XB03BAJ038A001010200198 | NHSA |
| 赛灵药业科技集团股份有限公司 | 国药准字H20254370 | 0.5mg | Category B (乙) | XB03BAJ038A001010200299 | NHSA |
| 深圳市中联制药有限公司 | 国药准字H20050320 | 0.5mg | Category B (乙) | XB03BAJ038A001010200543 | NHSA |
| 辽宁亿帆药业有限公司 | 国药准字H20041229 | 0.5mg | Category B (乙) | XB03BAJ038A001010201272 | NHSA |
| 卓和药业集团股份有限公司 | 国药准字H20051410 | 0.5mg | Category B (乙) | XB03BAJ038A001010201490 | NHSA |
| 江苏迪赛诺制药有限公司 | 国药准字H20052564 | 0.5mg | Category B (乙) | XB03BAJ038A001010201495 | NHSA |
| 南京海鲸药业股份有限公司 | 国药准字H20041642 | 0.5mg | Category B (乙) | XB03BAJ038A001010201579 | NHSA |
| 苏州第壹制药有限公司 | 国药准字H20253592 | 0.5mg | Category B (乙) | XB03BAJ038A001010201649 | NHSA |
| 苏州爱美津制药有限公司 | 国药准字H20051774 | 0.5mg | Category B (乙) | XB03BAJ038A001010201667 | NHSA |
| 卫材(中国)药业有限公司 | 国药准字H20143107 | 0.5mg(薄膜衣片) | Category B (乙) | XB03BAJ038A001010201693 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20052325 | 0.5mg | Category B (乙) | XB03BAJ038A001010201748 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001010202068 | NHSA |
| 四川成都同道堂制药有限责任公司 | 国药准字H20254466 | 0.5mg | Category B (乙) | XB03BAJ038A001010202128 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001010202273 | NHSA |
| 华北制药股份有限公司 | 国药准字H20031126 | 0.5mg | Category B (乙) | XB03BAJ038A001010202702 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001010202770 | NHSA |
| 亚宝药业集团股份有限公司 | 国药准字H20041767 | 0.5mg | Category B (乙) | XB03BAJ038A001010202959 | NHSA |
| 上海金不换兰考制药有限公司 | 国药准字H20253999 | 0.5mg | Category B (乙) | XB03BAJ038A001010203059 | NHSA |
| 山东鲁宁药业有限公司 | 国药准字H20255119 | 0.5mg | Category B (乙) | XB03BAJ038A001010204104 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001010204127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20254372 | 0.5mg | Category B (乙) | XB03BAJ038A001010204145 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001010204240 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20243796 | 0.5mg | Category B (乙) | XB03BAJ038A001010204658 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20253741 | 0.5mg | Category B (乙) | XB03BAJ038A001010204960 | NHSA |
| 江西科睿药业有限公司 | 国药准字H20051440 | 0.5mg | Category B (乙) | XB03BAJ038A001010205337 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001010205816 | NHSA |
| 宁夏洲洋制药有限公司 | 国药准字H20244226 | 0.5mg | Category B (乙) | XB03BAJ038A001010205908 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20244095 | 0.5mg | Category B (乙) | XB03BAJ038A001010206632 | NHSA |
| 焦作市博信制药有限公司 | 国药准字H20255252 | 0.5mg | Category B (乙) | XB03BAJ038A001010207193 | NHSA |
| 北京春风药业有限公司 | 国药准字H20243780 | 0.5mg | Category B (乙) | XB03BAJ038A001010209905 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20233571 | 0.5mg | Category B (乙) | XB03BAJ038A001010280760 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001010283004 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20234578 | 0.5mg | Category B (乙) | XB03BAJ038A001010283644 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001010285352 | NHSA |
| 北京星昊医药股份有限公司 | 国药准字H20060865 | 0.5mg | Category B (乙) | XB03BAJ038A001010300198 | NHSA |
| 辽宁亿帆药业有限公司 | 国药准字H20041229 | 0.5mg | Category B (乙) | XB03BAJ038A001010301272 | NHSA |
| 卓和药业集团股份有限公司 | 国药准字H20051410 | 0.5mg | Category B (乙) | XB03BAJ038A001010301490 | NHSA |
| 江苏迪赛诺制药有限公司 | 国药准字H20052564 | 0.5mg | Category B (乙) | XB03BAJ038A001010301495 | NHSA |
| 南京海鲸药业股份有限公司 | 国药准字H20041642 | 0.5mg | Category B (乙) | XB03BAJ038A001010301579 | NHSA |
| 苏州第壹制药有限公司 | 国药准字H20253592 | 0.5mg | Category B (乙) | XB03BAJ038A001010301649 | NHSA |
| 苏州爱美津制药有限公司 | 国药准字H20051774 | 0.5mg | Category B (乙) | XB03BAJ038A001010301667 | NHSA |
| 卫材(中国)药业有限公司 | 国药准字H20143107 | 0.5mg(薄膜衣片) | Category B (乙) | XB03BAJ038A001010301693 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20052325 | 0.5mg | Category B (乙) | XB03BAJ038A001010301748 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001010302068 | NHSA |
| 四川成都同道堂制药有限责任公司 | 国药准字H20254466 | 0.5mg | Category B (乙) | XB03BAJ038A001010302128 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001010302273 | NHSA |
| 华北制药股份有限公司 | 国药准字H20031126 | 0.5mg | Category B (乙) | XB03BAJ038A001010302702 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001010302770 | NHSA |
| 亚宝药业集团股份有限公司 | 国药准字H20041767 | 0.5mg | Category B (乙) | XB03BAJ038A001010302959 | NHSA |
| 上海金不换兰考制药有限公司 | 国药准字H20253999 | 0.5mg | Category B (乙) | XB03BAJ038A001010303059 | NHSA |
| 山东鲁宁药业有限公司 | 国药准字H20255119 | 0.5mg | Category B (乙) | XB03BAJ038A001010304104 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001010304127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20254372 | 0.5mg | Category B (乙) | XB03BAJ038A001010304145 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001010304240 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20243796 | 0.5mg | Category B (乙) | XB03BAJ038A001010304658 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20253741 | 0.5mg | Category B (乙) | XB03BAJ038A001010304960 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001010305816 | NHSA |
| 宁夏洲洋制药有限公司 | 国药准字H20244226 | 0.5mg | Category B (乙) | XB03BAJ038A001010305908 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20244095 | 0.5mg | Category B (乙) | XB03BAJ038A001010306632 | NHSA |
| 焦作市博信制药有限公司 | 国药准字H20255252 | 0.5mg | Category B (乙) | XB03BAJ038A001010307193 | NHSA |
| 北京春风药业有限公司 | 国药准字H20243780 | 0.5mg | Category B (乙) | XB03BAJ038A001010309905 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20233571 | 0.5mg | Category B (乙) | XB03BAJ038A001010380760 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001010383004 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20234578 | 0.5mg | Category B (乙) | XB03BAJ038A001010383644 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001010385352 | NHSA |
| 北京星昊医药股份有限公司 | 国药准字H20060865 | 0.5mg | Category B (乙) | XB03BAJ038A001010400198 | NHSA |
| 辽宁亿帆药业有限公司 | 国药准字H20041229 | 0.5mg | Category B (乙) | XB03BAJ038A001010401272 | NHSA |
| 江苏迪赛诺制药有限公司 | 国药准字H20052564 | 0.5mg | Category B (乙) | XB03BAJ038A001010401495 | NHSA |
| 南京海鲸药业股份有限公司 | 国药准字H20041642 | 0.5mg | Category B (乙) | XB03BAJ038A001010401579 | NHSA |
| 苏州第壹制药有限公司 | 国药准字H20253592 | 0.5mg | Category B (乙) | XB03BAJ038A001010401649 | NHSA |
| 苏州爱美津制药有限公司 | 国药准字H20051774 | 0.5mg | Category B (乙) | XB03BAJ038A001010401667 | NHSA |
| 扬子江药业集团南京海陵药业有限公司 | 国药准字H20052325 | 0.5mg | Category B (乙) | XB03BAJ038A001010401748 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001010402068 | NHSA |
| 四川成都同道堂制药有限责任公司 | 国药准字H20254466 | 0.5mg | Category B (乙) | XB03BAJ038A001010402128 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001010402273 | NHSA |
| 华北制药股份有限公司 | 国药准字H20031126 | 0.5mg | Category B (乙) | XB03BAJ038A001010402702 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001010402770 | NHSA |
| 上海金不换兰考制药有限公司 | 国药准字H20253999 | 0.5mg | Category B (乙) | XB03BAJ038A001010403059 | NHSA |
| 山东鲁宁药业有限公司 | 国药准字H20255119 | 0.5mg | Category B (乙) | XB03BAJ038A001010404104 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001010404127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20254372 | 0.5mg | Category B (乙) | XB03BAJ038A001010404145 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001010404240 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20253741 | 0.5mg | Category B (乙) | XB03BAJ038A001010404960 | NHSA |
| 江西科睿药业有限公司 | 国药准字H20051440 | 0.5mg | Category B (乙) | XB03BAJ038A001010405337 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001010405816 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20244095 | 0.5mg | Category B (乙) | XB03BAJ038A001010406632 | NHSA |
| 焦作市博信制药有限公司 | 国药准字H20255252 | 0.5mg | Category B (乙) | XB03BAJ038A001010407193 | NHSA |
| 北京春风药业有限公司 | 国药准字H20243780 | 0.5mg | Category B (乙) | XB03BAJ038A001010409905 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20233571 | 0.5mg | Category B (乙) | XB03BAJ038A001010480760 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001010483004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001010485352 | NHSA |
| 辽宁亿帆药业有限公司 | 国药准字H20041229 | 0.5mg | Category B (乙) | XB03BAJ038A001010501272 | NHSA |
| 江苏迪赛诺制药有限公司 | 国药准字H20052564 | 0.5mg | Category B (乙) | XB03BAJ038A001010501495 | NHSA |
| 南京海鲸药业股份有限公司 | 国药准字H20041642 | 0.5mg | Category B (乙) | XB03BAJ038A001010501579 | NHSA |
| 苏州第壹制药有限公司 | 国药准字H20253592 | 0.5mg | Category B (乙) | XB03BAJ038A001010501649 | NHSA |
| 苏州爱美津制药有限公司 | 国药准字H20051774 | 0.5mg | Category B (乙) | XB03BAJ038A001010501667 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001010502068 | NHSA |
| 四川成都同道堂制药有限责任公司 | 国药准字H20254466 | 0.5mg | Category B (乙) | XB03BAJ038A001010502128 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001010502273 | NHSA |
| 华北制药股份有限公司 | 国药准字H20031126 | 0.5mg | Category B (乙) | XB03BAJ038A001010502702 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001010502770 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001010504127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20254372 | 0.5mg | Category B (乙) | XB03BAJ038A001010504145 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001010504240 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20253741 | 0.5mg | Category B (乙) | XB03BAJ038A001010504960 | NHSA |
| 江西科睿药业有限公司 | 国药准字H20051440 | 0.5mg | Category B (乙) | XB03BAJ038A001010505337 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001010505816 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20244095 | 0.5mg | Category B (乙) | XB03BAJ038A001010506632 | NHSA |
| 焦作市博信制药有限公司 | 国药准字H20255252 | 0.5mg | Category B (乙) | XB03BAJ038A001010507193 | NHSA |
| 北京春风药业有限公司 | 国药准字H20243780 | 0.5mg | Category B (乙) | XB03BAJ038A001010509905 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20233571 | 0.5mg | Category B (乙) | XB03BAJ038A001010580760 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001010583004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001010585352 | NHSA |
| 辽宁亿帆药业有限公司 | 国药准字H20041229 | 0.5mg | Category B (乙) | XB03BAJ038A001010601272 | NHSA |
| 南京海鲸药业股份有限公司 | 国药准字H20041642 | 0.5mg | Category B (乙) | XB03BAJ038A001010601579 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001010602068 | NHSA |
| 四川成都同道堂制药有限责任公司 | 国药准字H20254466 | 0.5mg | Category B (乙) | XB03BAJ038A001010602128 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001010602273 | NHSA |
| 华北制药股份有限公司 | 国药准字H20031126 | 0.5mg | Category B (乙) | XB03BAJ038A001010602702 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001010602770 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001010604127 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001010604240 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20253741 | 0.5mg | Category B (乙) | XB03BAJ038A001010604960 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001010605816 | NHSA |
| 江苏德源药业股份有限公司 | 国药准字H20244095 | 0.5mg | Category B (乙) | XB03BAJ038A001010606632 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20233571 | 0.5mg | Category B (乙) | XB03BAJ038A001010680760 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001010683004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001010685352 | NHSA |
| 辽宁亿帆药业有限公司 | 国药准字H20041229 | 0.5mg | Category B (乙) | XB03BAJ038A001010701272 | NHSA |
| 南京海鲸药业股份有限公司 | 国药准字H20041642 | 0.5mg | Category B (乙) | XB03BAJ038A001010701579 | NHSA |
| 苏州爱美津制药有限公司 | 国药准字H20051774 | 0.5mg | Category B (乙) | XB03BAJ038A001010701667 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001010702068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001010702273 | NHSA |
| 华北制药股份有限公司 | 国药准字H20031126 | 0.5mg | Category B (乙) | XB03BAJ038A001010702702 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001010702770 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001010704127 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001010704240 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20253741 | 0.5mg | Category B (乙) | XB03BAJ038A001010704960 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001010705816 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20233571 | 0.5mg | Category B (乙) | XB03BAJ038A001010780760 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001010783004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001010785352 | NHSA |
| 辽宁亿帆药业有限公司 | 国药准字H20041229 | 0.5mg | Category B (乙) | XB03BAJ038A001010801272 | NHSA |
| 苏州爱美津制药有限公司 | 国药准字H20051774 | 0.5mg | Category B (乙) | XB03BAJ038A001010801667 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001010802068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001010802273 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001010802770 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001010804127 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001010804240 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20253741 | 0.5mg | Category B (乙) | XB03BAJ038A001010804960 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001010805816 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20233571 | 0.5mg | Category B (乙) | XB03BAJ038A001010880760 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001010883004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001010885352 | NHSA |
| 辽宁亿帆药业有限公司 | 国药准字H20041229 | 0.5mg | Category B (乙) | XB03BAJ038A001010901272 | NHSA |
| 苏州爱美津制药有限公司 | 国药准字H20051774 | 0.5mg | Category B (乙) | XB03BAJ038A001010901667 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001010902068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001010902273 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001010902770 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001010904240 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20253741 | 0.5mg | Category B (乙) | XB03BAJ038A001010904960 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001010905816 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20233571 | 0.5mg | Category B (乙) | XB03BAJ038A001010980760 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001010983004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001010985352 | NHSA |
| 辽宁亿帆药业有限公司 | 国药准字H20041229 | 0.5mg | Category B (乙) | XB03BAJ038A001011001272 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001011002068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001011002273 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001011002770 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001011004240 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20253741 | 0.5mg | Category B (乙) | XB03BAJ038A001011004960 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001011005816 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20233571 | 0.5mg | Category B (乙) | XB03BAJ038A001011080760 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001011083004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001011085352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001011102068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001011102273 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001011102770 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001011104240 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001011105816 | NHSA |
| 惠升生物制药股份有限公司 | 国药准字H20233571 | 0.5mg | Category B (乙) | XB03BAJ038A001011180760 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001011183004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001011185352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001011202068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001011202273 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001011202770 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001011204240 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001011205816 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001011283004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001011285352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001011302068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001011302273 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001011302770 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001011304240 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20050997 | 0.5mg | Category B (乙) | XB03BAJ038A001011305816 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001011383004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001011385352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001011402068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001011402273 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001011402770 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001011404240 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001011483004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001011485352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001011502068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001011502273 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20050168 | 0.5mg | Category B (乙) | XB03BAJ038A001011502770 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001011504240 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001011583004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001011585352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001011602068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001011602273 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001011604240 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001011683004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001011685352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001011702068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001011702273 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001011704240 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001011783004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001011785352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001011802068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001011802273 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001011804240 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001011883004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001011885352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001011902068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001011902273 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001011904240 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001011983004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001011985352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001012002068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001012002273 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001012004240 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001012083004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001012085352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001012102068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001012102273 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001012104240 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001012183004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001012185352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001012202068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001012202273 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001012204240 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001012283004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001012285352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001012302068 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001012302273 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001012304240 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001012383004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001012385352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001012402068 | NHSA |
| 烟台鲁银药业有限公司 | 国药准字H20244221 | 0.5mg | Category B (乙) | XB03BAJ038A001012404240 | NHSA |
| 河南比福制药股份有限公司 | 国药准字H20255795 | 0.5mg | Category B (乙) | XB03BAJ038A001012483004 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001012485352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001012502068 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001012585352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001012602068 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001012685352 | NHSA |
| 成都通德药业有限公司 | 国药准字H20243019 | 0.5mg | Category B (乙) | XB03BAJ038A001012702068 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001012785352 | NHSA |
| 济南高华制药有限公司 | 国药准字H20249835 | 0.5mg | Category B (乙) | XB03BAJ038A001012885352 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001020101014 | NHSA |
| 南京海鲸药业股份有限公司 | 国药准字H20041642 | 0.5mg | Category B (乙) | XB03BAJ038A001020101579 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001020102273 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001020104127 | NHSA |
| 南京海鲸药业股份有限公司 | 国药准字H20041642 | 0.5mg | Category B (乙) | XB03BAJ038A001020801579 | NHSA |
| 南京海鲸药业股份有限公司 | 国药准字H20041642 | 0.5mg | Category B (乙) | XB03BAJ038A001020901579 | NHSA |
| 南京海鲸药业股份有限公司 | 国药准字H20041642 | 0.5mg | Category B (乙) | XB03BAJ038A001021001579 | NHSA |
| 南京海鲸药业股份有限公司 | 国药准字H20041642 | 0.5mg | Category B (乙) | XB03BAJ038A001021101579 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001030101014 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001030102273 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001030104127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001030904127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001031004127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001031104127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001031204127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001031304127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001031404127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001031504127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001031604127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001031704127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001031804127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001031904127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001032004127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001032104127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001032204127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001032304127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001032404127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001032504127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001032604127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001032704127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001032804127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001032904127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001033004127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001033104127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001033204127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001033304127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20051425 | 0.5mg | Category B (乙) | XB03BAJ038A001033404127 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001040101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001050101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001060101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001070101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001080101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001090101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001100101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001110101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001120101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001130101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001140101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001150101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001160101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001170101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001180101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001190101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001200101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001210101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001220101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001230101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001240101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001250101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001260101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001270101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001280101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001290101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001300101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001310101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001320101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001330101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001340101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001350101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001360101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001370101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001380101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001390101014 | NHSA |
| 上海新亚药业闵行有限公司 | 国药准字H20052207 | 0.5mg | Category B (乙) | XB03BAJ038A017010100795 | NHSA |
| 上海新亚药业闵行有限公司 | 国药准字H20052207 | 0.5mg | Category B (乙) | XB03BAJ038A017010200795 | NHSA |
| 四川新斯顿制药股份有限公司 | 国药准字H20244481 | 0.5mg | Category B (乙) | XB03BAJ038A001040102273 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001400101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001410101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001420101014 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20256466 | 0.5mg | Category B (乙) | XB03BAJ038A001430101014 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 16 filings and 16 distinct first applicants.
Generic 16
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 江苏万高药业股份有限公司 | CYHS2601610 | Generic | 2026/07/07 | Not stated by source | CDE |
| 河北宏鑫堂药业有限公司;江苏诚康药业有限公司 | CYHS2502017 | Generic | 2025/06/07 | Not stated by source | CDE |
| 苏州俞氏药业有限公司 | CYHS2600448 | Generic | 2026/02/11 | Not stated by source | CDE |
| 山东诺明康药物研究院有限公司;山东诺禾康药业有限公司 | CYHS2602513 | Generic | 2026/10/13 | Not stated by source | CDE |
| 郑州韩都药业集团有限公司 | CYHS2602360 | Generic | 2026/09/21 | Not stated by source | CDE |
| 湖北长江瑞益医药科技有限公司;湖北广济药业股份有限公司 | CYHS2601428 | Generic | 2026/06/16 | Not stated by source | CDE |
| 浙江易泽达医药科技有限公司;浙江中同药业有限公司 | CYHS2601257 | Generic | 2026/06/02 | Not stated by source | CDE |
| 山东司邦得制药有限公司;山东诺禾康药业有限公司 | CYHS2601238 | Generic | 2026/06/01 | Not stated by source | CDE |
| 笛卡尔药业（哈尔滨）有限公司;哈尔滨三三药业有限公司 | CYHS2600378 | Generic | 2026/02/05 | Not stated by source | CDE |
| 山西同达药业有限公司 | CYHS2504176 | Generic | 2025/12/05 | Not stated by source | CDE |
| 杭州民生药物研究院有限公司;华益药业科技（安徽）有限公司 | CYHS2503460 | Generic | 2025/09/18 | Not stated by source | CDE |
| 淄博万杰制药有限公司 | CYHS2503036 | Generic | 2025/08/19 | Not stated by source | CDE |
| 天津柏海药业有限责任公司 | CYHS2502933 | Generic | 2025/08/12 | Not stated by source | CDE |
| 重庆药友制药有限责任公司 | CYHS2502746 | Generic | 2025/07/30 | Not stated by source | CDE |
| 赤峰维康生化制药有限公司 | CYHS2502719 | Generic | 2025/07/28 | Not stated by source | CDE |
| 山西汾河制药有限公司 | CYHS2502236 | Generic | 2025/06/21 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 8 filings and 8 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 江苏万高药业股份有限公司 | CYHS2601610 | Generic | 2026/07/07 | Not stated by source | CDE |
| 苏州俞氏药业有限公司 | CYHS2600448 | Generic | 2026/02/11 | Not stated by source | CDE |
| 山东诺明康药物研究院有限公司;山东诺禾康药业有限公司 | CYHS2602513 | Generic | 2026/10/13 | Not stated by source | CDE |
| 郑州韩都药业集团有限公司 | CYHS2602360 | Generic | 2026/09/21 | Not stated by source | CDE |
| 湖北长江瑞益医药科技有限公司;湖北广济药业股份有限公司 | CYHS2601428 | Generic | 2026/06/16 | Not stated by source | CDE |
| 浙江易泽达医药科技有限公司;浙江中同药业有限公司 | CYHS2601257 | Generic | 2026/06/02 | Not stated by source | CDE |
| 山东司邦得制药有限公司;山东诺禾康药业有限公司 | CYHS2601238 | Generic | 2026/06/01 | Not stated by source | CDE |
| 笛卡尔药业（哈尔滨）有限公司;哈尔滨三三药业有限公司 | CYHS2600378 | Generic | 2026/02/05 | Not stated by source | CDE |
API registrations
Non-component matches: 21 companies with A status and 5 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 甲钴胺 | HealthTech Bio Actives, S.L.U. | Y20250001193 | I | Exact ingredient | 2025/12/04 | CDE |
| 甲钴胺 | HealthTech Bio Actives, S.L.U. | Y20210000599 | I | Exact ingredient | 2024/02/27 | CDE |
| 甲钴胺 | 宁夏金维制药股份有限公司 | Y20190009859 | A | Exact ingredient | 2024/10/26 | CDE |
| 甲钴胺 | 河北华荣制药有限公司 | Y20190009577 | A | Exact ingredient | 2024/11/21 | CDE |
| 甲钴胺 | Eisai Co., Ltd. | Y20190009090 | A | Exact ingredient | 2024/09/03 | CDE |
| 甲钴胺 | 山东科源制药股份有限公司 | Y20190008797 | A | Exact ingredient | 2025/06/28 | CDE |
| 甲钴胺 | 海南斯达制药有限公司 | Y20190008459 | A | Exact ingredient | — | CDE |
| 甲钴胺 | 玉星生物(集团)股份有限公司 | Y20190007621 | A | Exact ingredient | 2024/04/09 | CDE |
| 甲钴胺 | 兰西哈三联制药有限公司 | Y20190005725 | A | Exact ingredient | 2025/09/19 | CDE |
| 甲钴胺 | 江西科睿药业有限公司 | Y20190005609 | A | Exact ingredient | 2024/12/27 | CDE |
| 甲钴胺 | 重庆莱美隆宇药业有限公司 | Y20190005171 | A | Exact ingredient | 2025/09/04 | CDE |
| 甲钴胺 | 河北华北制药华恒药业有限公司 | Y20190005157 | A | Exact ingredient | 2024/08/02 | CDE |
| 甲钴胺 | 福建金山生物制药股份有限公司 | Y20190005114 | A | Exact ingredient | — | CDE |
| 甲钴胺 | 江苏四环生物制药有限公司 | Y20190004322 | A | Exact ingredient | 2025/07/08 | CDE |
| 甲钴胺 | 佛山市南海北沙制药有限公司 | Y20190004308 | A | Exact ingredient | 2025/10/12 | CDE |
| 甲钴胺 | 津药药业股份有限公司 | Y20190004126 | A | Exact ingredient | 2024/01/06 | CDE |
| 甲钴胺 | 南京瑞尔医药有限公司 | Y20190003770 | A | Exact ingredient | — | CDE |
| 甲钴胺 | 山东海山药业有限公司 | Y20190003661 | A | Exact ingredient | — | CDE |
| 甲钴胺 | 四川德峰药业有限公司 | Y20190003172 | A | Exact ingredient | 2023/03/24 | CDE |
| 甲钴胺 | 扬子江药业集团江苏海慈生物药业有限公司 | Y20190002712 | A | Exact ingredient | 2025/03/27 | CDE |
| 甲钴胺 | 亚宝药业集团股份有限公司 | Y20190002307 | A | Exact ingredient | 2026/06/06 | CDE |
| 甲钴胺 | 山东辰龙药业有限公司 | Y20190002099 | A | Exact ingredient | 2024/02/08 | CDE |
| 甲钴胺 | 重庆药友制药有限责任公司 | Y20190001955 | A | Exact ingredient | 2025/04/05 | CDE |
| 甲钴胺 | Sanofi Chimie | Y20190000022 | I | Exact ingredient | 2019/08/12 | CDE |
| 甲钴胺 | 河北华荣制药有限公司 | Y20190000015 | I | Exact ingredient | 2019/03/26 | CDE |
| 甲钴胺 | 宁夏金维制药股份有限公司 | Y20180001157 | I | Exact ingredient | 2018/09/29 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/11/03Marketing application approved
四川依科制药有限公司
CYHS2502517 · 国药准字H20266456
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 93 ↗ -
2026/10/13Accepted
山东诺明康药物研究院有限公司;山东诺禾康药业有限公司
CYHS2602513
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ -
2026/09/21Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Mecobalamin Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy